Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Neuronetics Analyst Ratings and Price Targets | NASDAQ:STIM | Benzinga
Neuronetics Inc has a consensus price target of $6.5 based on the ratings of 5 analysts. The high is $8 issued by Canaccord Genuity on March 5, 2025. The low is $3 issued by JMP Securities on August 14, 2024. The 3 most-recent analyst ratings were released by Canaccord Genuity, Citizens Capital Markets, and JMP Securities on March 5, 2025, March 5, 2025, and August 14, 2024, respectively. With an average price target of $6 between Canaccord Genuity, Citizens Capital Markets, and JMP Securities, there's an implied 25.00% upside for Neuronetics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
Citizens Capital Markets
JMP Securities
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Neuronetics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/05/2025 | Buy Now | 66.67% | Canaccord Genuity | William Plovanic58% | $5 → $8 | Maintains | Buy | Get Alert |
| 03/05/2025 | Buy Now | 45.83% | Citizens Capital Markets | Daniel Stauder34% | $3 → $7 | Maintains | Market Outperform | Get Alert |
| 08/14/2024 | Buy Now | -37.5% | JMP Securities | David Turkaly55% | $7 → $3 | Maintains | Market Outperform | Get Alert |
| 08/13/2024 | Buy Now | -37.5% | Canaccord Genuity | William Plovanic58% | $6 → $3 | Maintains | Buy | Get Alert |
| 08/12/2024 | Buy Now | — | William Blair | Margaret Kaczor37% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/14/2024 | Buy Now | — | William Blair | Margaret Kaczor37% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 03/06/2024 | Buy Now | 66.67% | Piper Sandler | Adam Maeder65% | $7 → $8 | Reiterates | Overweight → Overweight | Get Alert |
| 05/10/2023 | Buy Now | 150% | JMP Securities | David Turkaly55% | → $12 | Reiterates | → Market Outperform | Get Alert |
| 03/08/2023 | Buy Now | 45.83% | Canaccord Genuity | William Plovanic58% | $9 → $7 | Maintains | Buy | Get Alert |
| 03/08/2023 | Buy Now | 150% | JMP Securities | David Turkaly55% | → $12 | Reiterates | → Market Outperform | Get Alert |
FAQ
What is the target price for Neuronetics (STIM) stock?
The latest price target for Neuronetics (NASDAQ:STIM) was reported by Canaccord Genuity on March 5, 2025. The analyst firm set a price target for $8.00 expecting STIM to rise to within 12 months (a possible 66.67% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Neuronetics (STIM)?
The latest analyst rating for Neuronetics (NASDAQ:STIM) was provided by Canaccord Genuity, and Neuronetics maintained their buy rating.
When was the last upgrade for Neuronetics (STIM)?
The last upgrade for Neuronetics Inc happened on May 14, 2024 when William Blair raised their price target to N/A. William Blair previously had a market perform for Neuronetics Inc.
When was the last downgrade for Neuronetics (STIM)?
The last downgrade for Neuronetics Inc happened on August 12, 2024 when William Blair changed their price target from N/A to N/A for Neuronetics Inc.
When is the next analyst rating going to be posted or updated for Neuronetics (STIM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Neuronetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Neuronetics was filed on March 5, 2025 so you should expect the next rating to be made available sometime around March 5, 2026.
Is the Analyst Rating Neuronetics (STIM) correct?
While ratings are subjective and will change, the latest Neuronetics (STIM) rating was a maintained with a price target of $5.00 to $8.00. The current price Neuronetics (STIM) is trading at is $4.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.